Edition:
India

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,591.70INR
14 Dec 2018
Change (% chg)

Rs-5.15 (-0.20%)
Prev Close
Rs2,596.85
Open
Rs2,595.00
Day's High
Rs2,609.60
Day's Low
Rs2,568.00
Volume
586,360
Avg. Vol
952,583
52-wk High
Rs2,749.95
52-wk Low
Rs1,887.00

Chart for

About

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and... (more)

Overall

Beta: 0.11
Market Cap(Mil.): Rs394,104.81
Shares Outstanding(Mil.): 165.88
Dividend: 20.00
Yield (%): 0.84

Financials

  REDY.NS Industry Sector
P/E (TTM): 32.79 31.13 34.39
EPS (TTM): 72.46 -- --
ROI: -- 15.55 14.96
ROE: -- 16.92 16.52

BUZZ-India's Dr.Reddy's tumbles after U.S. court puts Suboxone copy sale on hold

** Dr.Reddy's Laboratories Ltd shares fall as much as 6.7 pct to 2,534.1 rupees, their lowest since Nov 26

12 Dec 2018

Dr. Reddy's shares spike after favourable generic drug ruling

Shares of Indian drugmaker Dr. Reddy's Laboratories Ltd jumped nearly 9 percent on Wednesday, their sharpest intraday gain in a year, after a U.S. court allowed the company to sell a copycat version of Indivior Plc's opioid treatment Suboxone Film.

21 Nov 2018

India's Dr. Reddy's shares spike after favourable generic drug ruling

Nov 21 Shares of Indian drugmaker Dr. Reddy's Laboratories Ltd jumped nearly 9 percent on Wednesday, their sharpest intraday gain in a year, after a U.S. court allowed the company to sell a copycat version of Indivior Plc's opioid treatment Suboxone Film.

21 Nov 2018

BUZZ-India's Dr. Reddy's rises most in 1 year as U.S. court allows generic drug sale

** Dr. Reddy's Laboratories Ltd shares surge as much as 8.7 pct to 2,655 rupees, their highest since Sept. 26

21 Nov 2018

UPDATE 2-Cost cuts help drugmaker Indivior as it battles cheap rival

* Shares give back early gains to trade lower (Adds details on the company's drugs, background, comments)

01 Nov 2018

BUZZ-India's Dr.Reddy's falls after U.S. FDA issues observations on plant

** Shares of Indian drugmaker Dr.Reddy's Laboratories Ltd drop as much as 6.6 pct to 2,423.05 rupees, their biggest daily pct loss since July 16

31 Oct 2018

Indian shares perk up on strong corporate earnings boost

Oct 29 Indian shares opened on a positive note on Monday as investors lauded a solid set of second-quarter earnings in large-cap companies such as ICICI Bank Ltd and Dr. Reddy's Laboratories Ltd.

29 Oct 2018

BUZZ-India's Dr.Reddy's rises on strong Q2 results; Macquarie, Citi raise TP

** Shares of Indian drugmaker Dr.Reddy's Laboratories rise as much as 6.4 pct to 2,559 rupees in their biggest daily pct gain since May 22

29 Oct 2018

Dr. Reddy's second-quarter profit soars past market estimates

Dr.Reddy's Laboratories posted a better-than-expected rise in second-quarter profit as higher sales in some emerging countries offset a marginal decline in business in North America, a key market for the Indian generic drugmaker.

26 Oct 2018

UPDATE 1-Indian drugmaker Dr. Reddy's Q2 profit soars past market estimates

Oct 26 Dr.Reddy's Laboratories posted a better-than-expected rise in second-quarter profit as higher sales in some emerging countries offset a marginal decline in business in North America, a key market for the Indian generic drugmaker.

26 Oct 2018

Earnings vs. Estimates